Boukephalos is a biotech startup developing Longevity Cancer TherapeuticsTM (LCTs), cancer drugs that actually work: has high efficacy, but no off-target toxicity, severe/long-lasting side effects, or the high risk of recurrence that always keeps ex-cancer patients worried about metastasis.

This is achievable only by using a fundamentally different approach from major cancer drugs today. LCTs cure cancer via multi-front molecular and cellular activation of the innate and the adaptive immune systems by using the best immune stimulators that work through the innate and the adaptive immune systems.

Given their efficacy+safety, they can cure cancer not only when but also before it fully occurs (as pre-cancer: saplings of cancer), providing a truly disruptive solution to cancer.

Create your website with WordPress.com
Get started
%d bloggers like this: